Efficacy & Tolerability of a Topical High Concentration Capsaicin (TRPV1 Agonist) in PHN & PDPN of the Feet

Time: 9:00 am
day: Day Two


  • In clinical trials most common ARs were application site reactions
  • Sharing statistically significant improvements in pain relief in patients with PDPN and PHN
  • Feedback on clinical trial results: It was well tolerated and was not associated with any negative functional or neurological safety consequences